21 unchanged sentences
OTHER INFORMATION
+Added: DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
+Added: Not applicable.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
4 unchanged sentences
Incorporated by reference from the information in our Proxy Statement for our 2022 Annual Meeting of Stockholders, which we will file with the SEC within 120 days of the end of the fiscal year to which this Annual Report on Form 10-K relates.
+Added: Securities Authorized for Issuance Under Equity Compensation Plans
+Added: We intend to file with the SEC a definitive Proxy Statement, which we refer to herein as the Proxy Statement, not later than 120 days after the close of the fiscal year ended December 31, 2021.
+Added: The information required by this item relating to our equity compensation plans is incorporated herein by reference to the information contained under the section captioned “Equity Compensation Plan Information” of the Proxy Statement.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
5 unchanged sentences
The following consolidated financial statements are filed as part of this report under “Item 8 — Financial Statements and Supplementary Data:”
−Removed: Report of Independent Registered Public Accounting Firm
+Added: Report of Independent Registered Public Accounting Firm (PCAOB ID 238)
Consolidated Balance Sheets as of December 31, 2021 and 2020
37 unchanged sentences
001-36407) for the quarterly period ended June 30, 2018 and incorporated herein by reference)
−Removed: 10.11** Form of Performance Stock Unit Award Agreement under 2018 Stock Incentive Plan, as amended (filed as Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on August 6, 2019 (File No.
−Removed: 001-36407) for the quarterly period ended June 30, 2019 and incorporated herein by reference)
−Removed: 10.12**# Amended and Restated Annual Incentive Program, as amended
+Added: 10.11# Forms of Nonstatutory Stock Option Agreements under 2018 Stock Incentive Plan, as amended
+Added: 10.12**# Forms of Stock Unit Award Agreements under 2018 Stock Incentive Plan, as amended
+Added: 10.13** Amended and Restated Annual Incentive Program, as amended (filed as Exhibit 10.1 2 to the R egistrant's Annual Report on Form 10-K filed on February 11, 2021 (File No.
+Added: 001-3 6407) for th e year ended December 31, 2020 and incorporated herein by reference )
+Added: 10.14** Employment Agreement between the Registrant and Dr.
+Added: Greenstreet dated December 14, 2021 (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on December 20, 2021 (File No.
+Added: 001-36407) and incorporated herein by reference)
10.15** Letter Agreement between the Registrant and John M.
Maraganore, Ph.D.
−Removed: dated October 30, 2002 (filed as Exhibit 10.7 to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: dated October 26, 2021 (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on October 28, 2021 (File No.
001-36407) and incorporated herein by reference)
2 unchanged sentences
001-36407) for the quarterly period ended September 30, 2020 and incorporated herein by reference)
−Removed: 10.15** Letter Agreement between the Registrant and Yvonne L.
−Removed: Greenstreet, MBChB dated August 12, 2016 (filed as Exhibit 10.14 to the Registrant’s Annual Report on Form 10-K filed on February 15, 2017 (File No.
−Removed: 001-36407) for the year ended December 31, 2016 and incorporated herein by reference)
+Added: 10.17** Letter Agreement between the Registrant and Laurie B.
+Added: Keating dated September 6, 2021 (filed as Exhibit 10.1 to Registrant’s Quarterly Report on Form 10-Q filed on October 28, 2021 (File No.
+Added: 001-36407) for the quarterly period ended September 30, 2021 and incorporated herein by reference)
10.18** Consulting Agreement dated as of March 1, 2006 by and between the Registrant and Phillip A.
9 unchanged sentences
001-36407) for the quarterly period ended September 30, 2017 and incorporated herein by reference)
−Removed: 10.20**# Change in Control Agreement dated November 2, 2020 by and between the Registrant and John M.
10.22 Lease, dated as of September 26, 2003 by and between the Registrant and Three Hundred Third Street LLC (filed as Exhibit 10.15 to the Registrant’s Registration Statement on Form S-1 (File No.
23 unchanged sentences
001-36407) for the quarterly period ended September 30, 2016 and incorporated herein by reference)
+Added: 10.31 Second Amendment to Lease entered into as of April 28, 2021 by and between BMR-Fresh Pond Research Park LLC and the Registrant (filed as Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on August 3, 2021 (File No.
+Added: 001-36407) for the quarterly period ended June 30, 2021 and incorporated herein by reference)
10.32 Lease dated as of March 18, 2015 between RREEF America REIT II CORP.
106 unchanged sentences
001-36407) for the quarterly period ended September 30, 2020 and incorporated herein by reference)
+Added: Amendment No.
+Added: 1 to Co-Development Agreement between the Registrant and BXLS V Bodyguard – PCP L.P.
+Added: and BXLS Family Investment Partnership V – ESC L.P.
+Added: dated November 23, 2021
10.71† Patent Cross-License Agreement dated April 3, 2020 between Dicerna Pharmaceuticals, Inc.
15 unchanged sentences
104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.)
−Removed: * Schedules, exhibits and similar supporting attachments or agreements to the Stock Purchase Agreement are omitted pursuant to Item 601(b)(2) of Regulation S-K.
+Added: * Schedules, exhibits and similar supporting attachments or agreements to this exhibit are omitted pursuant to Item 601(b)(2) of Regulation S-K.
The Registrant agrees to furnish a supplemental copy of any omitted schedule or similar attachment to the Securities and Exchange Commission upon request.
3 unchanged sentences
FORM 10-K SUMMARY
−Removed: Not applicable.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 10, 2022.
ALNYLAM PHARMACEUTICALS, INC.
−Removed: Maraganore, Ph.D.
−Removed: Maraganore, Ph.D.
+Added: /s/ Yvonne L.
+Added: Greenstreet, MBChB
+Added: Greenstreet, MBChB
Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, the Report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated as of February 10, 2022.
−Removed: Maraganore, Ph.D.
−Removed: Director and Chief Executive Officer
−Removed: Maraganore, Ph.D.
−Removed: (Principal Executive Officer)
+Added: /s/ Yvonne L.
+Added: Greenstreet, MBChB Director and Chief Executive Officer
+Added: Greenstreet, MBChB (Principal Executive Officer)
/s/ Jeffrey V.
21 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.